IONIS PHARMACEUTICALS INC
For the period ended Sep 30, 2026. Filed Nov 9, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2026 · Filed Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Other Information
ITEM 5.OTHER INFORMATION
Trading Plans
During the quarter ended September 30, 2026, our directors and officers (as defined in Rule 16a-1(f) under the Exchange Act), or Section 16 officers and directors, did notadopt orterminate contracts, instructions or written plans for the purchase or sale of our securities.
Index
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.